CNBX PHARMACEUTICALS INC. Available-for-sale Equity Securities, Gross Unrealized Gain
CNBX PHARMACEUTICALS INC. (CNBX) reported Available-for-sale Equity Securities, Gross Unrealized Gain of $48.55 thousand for the 9-month period ending 2020-05-31, per its 10-Q filed 2020-07-14.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleEquitySecuritiesGrossUnrealizedGain · last filed 2020-07-14
- CNBX PHARMACEUTICALS INC. available-for-sale equity securities, gross unrealized gain for the quarter ending 2020-05-31 was -$31.98K.
- CNBX PHARMACEUTICALS INC. available-for-sale equity securities, gross unrealized gain for the quarter ending 2020-02-29 was $21.79K, a 99.52% decline year-over-year.
- CNBX PHARMACEUTICALS INC. available-for-sale equity securities, gross unrealized gain for the quarter ending 2019-11-30 was $58.73K.
- CNBX PHARMACEUTICALS INC. available-for-sale equity securities, gross unrealized gain for the quarter ending 2019-05-31 was -$4.51M.
| Period end | Available-for-sale Equity Securities, Gross Unrealized Gain 3 month | Available-for-sale Equity Securities, Gross Unrealized Gain 6 month | Available-for-sale Equity Securities, Gross Unrealized Gain 9 month |
|---|---|---|---|
| 2020-05-31 | -$31.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-14 | -$10.18K derived: sum of 2 quarters · filed 2020-07-14 | $48.55K 10-Q · filed 2020-07-14 |
| 2020-02-29 | $21.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $80.52K 10-Q · filed 2020-04-13 | |
| 2019-11-30 | $58.73K 10-Q · filed 2020-01-14 | ||
| 2019-05-31 | -$4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-07-14 | $68.53K derived: sum of 2 quarters · filed 2020-07-14 | $68.53K 10-Q · filed 2020-07-14 |
| 2019-02-28 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-13 | $4.58M 10-Q · filed 2020-04-13 | |
| 2018-11-30 | $0.00 10-Q · filed 2020-01-14 | ||
| 2018-05-31 | $0.00 10-Q · filed 2019-07-15 |